BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32963458)

  • 1. Integration of stereotactic radiosurgery or whole brain radiation therapy with immunotherapy for treatment of brain metastases.
    Su Z; Zhou L; Xue J; Lu Y
    Chin J Cancer Res; 2020 Aug; 32(4):448-466. PubMed ID: 32963458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of immuno-oncology with stereotactic radiosurgery in the management of brain metastases.
    Lehrer EJ; McGee HM; Sheehan JP; Trifiletti DM
    J Neurooncol; 2021 Jan; 151(1):75-84. PubMed ID: 32052355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases.
    Lehrer EJ; McGee HM; Peterson JL; Vallow L; Ruiz-Garcia H; Zaorsky NG; Sharma S; Trifiletti DM
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiosurgery with immune checkpoint inhibitors for brain metastases: a meta-analysis study.
    Badrigilan S; Meola A; Chang SD; Rezaeian S; Nemati H; Almasi T; Rostampour N
    Br J Neurosurg; 2023 Dec; 37(6):1533-1543. PubMed ID: 34979828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abscopal effect: inducing immunogenicity in the treatment of brain metastases secondary to lung cancer and melanoma.
    Tracz JA; Donnelly BM; Ngu S; Vojnic M; Wernicke AG; D'Amico RS
    J Neurooncol; 2023 May; 163(1):1-14. PubMed ID: 37086369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases.
    Tonse R; Tom MC; Mehta MP; Ahluwalia MS; Kotecha R
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
    Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
    J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data.
    Lehrer EJ; Peterson J; Brown PD; Sheehan JP; Quiñones-Hinojosa A; Zaorsky NG; Trifiletti DM
    Radiother Oncol; 2019 Jan; 130():104-112. PubMed ID: 30241791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
    El Shafie RA; Celik A; Weber D; Schmitt D; Lang K; König L; Bernhardt D; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S
    J Neurooncol; 2020 May; 147(3):607-618. PubMed ID: 32239433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis.
    Su Z; Zhang L; Xue S; Wang Y; Ding R
    Open Life Sci; 2023; 18(1):20220559. PubMed ID: 36874630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
    El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
    Front Oncol; 2020; 10():693. PubMed ID: 32477942
    [No Abstract]   [Full Text] [Related]  

  • 14. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
    Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK; Shu HK; Crocker I
    J Neurooncol; 2014 Dec; 120(3):657-63. PubMed ID: 25189789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
    Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
    BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.
    Chu X; Niu L; Xiao G; Peng H; Deng F; Liu Z; Wu H; Yang L; Tan Z; Li Z; Zhou R
    Front Immunol; 2022; 13():875488. PubMed ID: 35693805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases.
    Yoo KH; Park DJ; Choi JH; Marianayagam NJ; Lim M; Meola A; Chang SD
    Front Oncol; 2023; 13():1223599. PubMed ID: 37637032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for brain metastases from small-cell lung cancer in distinct clinical indications and scenarios.
    Kepka L; Socha J; Sas-Korczynska B
    J Thorac Dis; 2021 May; 13(5):3269-3278. PubMed ID: 34164219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.